July 9, 2024 — Bracco and Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, has announced the appointment of Marco Campione as its new Chief Executive Officer (CEO), reporting to Bracco Imaging CEO Fulvio Renoldi Bracco.

Because of its position on the front lines of diagnoses, medical imaging has a particularly unique role in mitigating healthcare inequity

Investing in women’s health should not merely be a metric on the equity dashboard — it should drive policy and tactical interventions forward. The disparity in health outcomes between genders, compounded further by racial inequities, represents a significant portion of the overarching challenge of health inequality.
Once clouds prove they can address the needs of everyone in a cost-effective manner, the industry will see the cloud become almost universally adopted

Back in 1966, Joni Mitchell sang these words in her song “Both Sides Now:” 

     I’ve looked at clouds from both sides now

     From up and down and still somehow

     It’s cloud illusions I recall

     I really don’t know clouds at all 

 
Last Read

ITN conducts a bi-monthly survey to its readers on a variety of topics, which is used to create the Last Read, a unique mix of radiology facts, figures and trends. This column offers a venue to get to know your colleagues, and see where you stand on different issues. Do you have a question you want us to ask? Contact Editorial Director Melinda Taschetta-Millane at [email protected].

As we come upon the calendar’s mid-year mark, it is time once again for the ITN team to begin its annual strategic planning for 2025. And we’d like to hear from you. By now, you have probably noticed the new content features ITN introduced this year, including the One on One … multimedia interview series, where we’ve held deep-dive discussions with respected industry professionals on impactful issues and initiatives.

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced its acquisition of the global rights of Life Molecular Imaging’s RM2, targeting the gastrin-releasing peptide receptor (GRP

Have a safe 4th of July from ITN in Chicago

The ITN team wishes you a safe and happy 4th of July!

July 3, 2024 — A new Harvey L. Neiman Health Policy Institute (HPI) study found that radiologists interpreted 72.1% of all imaging studies for Medicare fee-for-service beneficiaries in 2022, with the remaining 27.9% performed by other types of clinicians.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now